Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

RESTORE trial results presented at AHA meeting

Nov. 22, 1996

ACE inhibitor-AT antagonist combination therapy results presented at AHA congress

Nov. 22, 1996

Calcium channel blocker update

Nov. 22, 1996

Pfizer's antiasthma drug R&D

Nov. 20, 1996

Latest findings on the diagnosis and treatment of erectile dysfunction

Nov. 15, 1996

Salagen Tablets more effective given during radiation therapy

Nov. 15, 1996

Rabeprazole + amoxicillin for eradication of H. pylori

Nov. 8, 1996

CV Therapeutics reports novel adenosine antagonist

Nov. 8, 1996

Focus on present and future migraine therapy

Nov. 8, 1996

Antiarrhythmic 1,4-benzodiazepine from Merck

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...